166 related articles for article (PubMed ID: 29306458)
1. Impact of subclinical hypothyroidism on clinical outcomes following percutaneous coronary intervention.
Lee Y; Lim YH; Shin JH; Park J; Shin J
Int J Cardiol; 2018 Feb; 253():155-160. PubMed ID: 29306458
[TBL] [Abstract][Full Text] [Related]
2. Impact of persistent subclinical hypothyroidism on clinical outcomes in non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
Han C; Xu K; Wang L; Zhang Y; Zhang R; Wei A; Dong L; Hu Y; Xu J; Li W; Li T; Liu C; Qi W; Jin D; Zhang J; Cong H
Clin Endocrinol (Oxf); 2022 Jan; 96(1):70-81. PubMed ID: 34636447
[TBL] [Abstract][Full Text] [Related]
3. The impact of subclinical hypothyroidism on long-term outcomes in older patients undergoing percutaneous coronary intervention.
Liu YS; Wei M; Wang L; Liu G; Ma GP; Ono K; Cao ZL; Yang M; Zheng MQ
BMC Endocr Disord; 2021 Mar; 21(1):43. PubMed ID: 33673843
[TBL] [Abstract][Full Text] [Related]
4. Unknown Subclinical Hypothyroidism and In-Hospital Outcomes and Short- and Long-Term All-Cause Mortality among ST Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
Izkhakov E; Zahler D; Rozenfeld KL; Ravid D; Banai S; Topilsky Y; Stern N; Greenman Y; Shacham Y
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33256094
[TBL] [Abstract][Full Text] [Related]
5. Relation of Subclinical Hypothyroidism to Acute Kidney Injury Among ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
Zahler D; Izkhakov E; Rozenfeld KL; Ravid D; Banai S; Topilsky Y; Shacham Y
Isr Med Assoc J; 2019 Oct; 21(10):692-695. PubMed ID: 31599513
[TBL] [Abstract][Full Text] [Related]
6. Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults.
Tseng FY; Lin WY; Lin CC; Lee LT; Li TC; Sung PK; Huang KC
J Am Coll Cardiol; 2012 Aug; 60(8):730-7. PubMed ID: 22726629
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Metabolic Syndrome on Clinical Outcomes After Everolimus-Eluting Stent Implantation.
Lee Y; Lim YH; Shin JH; Park J; Shin J; Kim KS
Am J Cardiol; 2015 Sep; 116(5):717-24. PubMed ID: 26115900
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
[TBL] [Abstract][Full Text] [Related]
10. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
11. Subclinical Hypothyroidism and Clinical Outcomes After Percutaneous Coronary Intervention: A Meta-Analysis.
Ang SP; Chia JE; Jaiswal V; Bandyopadhyay D; Iglesias J; Mohan GVK; Gautam S; Win T; Kumar T; Iqbal A; Chia TH; Aronow W
Curr Probl Cardiol; 2023 Aug; 48(8):101719. PubMed ID: 36967069
[TBL] [Abstract][Full Text] [Related]
12. Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era.
Midwall S; Swaminathan RV; Charitakis K; Kim LK; Gordin J; Hriljac I; Minutello RM; Bergman G; Wong SC; Feldman DN
J Invasive Cardiol; 2013 Mar; 25(3):132-6. PubMed ID: 23468442
[TBL] [Abstract][Full Text] [Related]
13. Subclinical hypothyroidism and mortality in a large Austrian cohort: a possible impact on treatment?
Kovar FM; Fang IF; Perkmann T; Haslacher H; Slavka G; Födinger M; Endler G; Wagner OF
Wien Klin Wochenschr; 2015 Dec; 127(23-24):924-30. PubMed ID: 26373750
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study.
Nochioka K; Biering-Sørensen T; Hansen KW; Sørensen R; Pedersen S; Jørgensen PG; Iversen A; Shimokawa H; Jeger R; Kaiser C; Pfisterer M; Galatius S;
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):778-786. PubMed ID: 27166320
[TBL] [Abstract][Full Text] [Related]
15. Optical Coherence Tomography-Guided Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Prospective Propensity-Matched Cohort of the Thrombectomy Versus Percutaneous Coronary Intervention Alone Trial.
Sheth TN; Kajander OA; Lavi S; Bhindi R; Cantor WJ; Cheema AN; Stankovic G; Niemelä K; Natarajan MK; Shestakovska O; Tittarelli R; Meeks B; Jolly SS
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003414. PubMed ID: 27056766
[TBL] [Abstract][Full Text] [Related]
16. Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry.
Chandrasekhar J; Baber U; Sartori S; Aquino M; Tomey M; Kruckoff M; Moliterno D; Henry TD; Weisz G; Gibson CM; Iakovou I; Kini A; Faggioni M; Vogel B; Farhan S; Colombo A; Steg PG; Witzenbichler B; Chieffo A; Cohen D; Stuckey T; Ariti C; Pocock S; Dangas G; Mehran R
Int J Cardiol; 2017 Sep; 243():132-139. PubMed ID: 28554669
[TBL] [Abstract][Full Text] [Related]
17. Data on the impact of subclinical hypothyroidism on clinical outcomes following percutaneous coronary intervention.
Lee Y; Lim YH; Shin JH; Park J; Shin J
Data Brief; 2018 Feb; 16():630-634. PubMed ID: 29276739
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes among patients with subclinical hypothyroidism undergoing primary percutaneous coronary intervention.
Al-Gburi AJ; Al-Obaidi SR; Abdullah WH
Ghana Med J; 2023 Jan; 57(1):37-42. PubMed ID: 37576368
[TBL] [Abstract][Full Text] [Related]
19. Subclinical hypothyroidism is associated with increased risk for cancer mortality in adult Taiwanese-a 10 years population-based cohort.
Tseng FY; Lin WY; Li CI; Li TC; Lin CC; Huang KC
PLoS One; 2015; 10(4):e0122955. PubMed ID: 25830770
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
